The Senate health committee on Tuesday (Feb. 9) will hold the first installment of a long-awaited markup of its counterpart to the House-passed Cures legislation, with the committee's lineup including a revised draft of legislation to improve electronic health records, as well as bipartisan bills to streamline FDA's reviews of innovate medical devices, bolster FDA's oversight of reused devices, accelerate the approval process of genetically targeted drugs, identify and remove barriers faced by the next generation of researchers within the National Institutes of Health, among other issues.